Experienced radio-guided surgery teams can successfully perform minimally invasive radio-guided parathyroidectomy without Intraoperative parathyroid hormone assays

被引:0
|
作者
Caudle, Abigail S.
Brier, Sarah E.
Calvo, Benjamin F.
Kim, Hong Jin
Meyers, Michael O.
Ollila, David W.
机构
[1] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Sch Med, Chapel Hill, NC 27599 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Minimally invasive parathyroidectomy is an accepted treatment option for primary hyperparathyroidism. The need for intraoperative parathyroid hormone assays (iPTH) to confirm adenoma removal remains controversial. We studied minimally invasive radio-guided parathyroidectomy (MIRP) performed using preoperative sestamibi localization studies, intraoperative gamma detection probe, and the selective use of frozen section pathology without the use of iPTH. This is a single institution review of patients with primary hyperparathyroidism treated with MIRP by surgeons experienced in radio-guided surgery between October 1, 1998 and July 15, 2005. Information was obtained by reviewing computer medical records as well as contacting primary care physicians. Factors evaluated included laboratory values, pathology results, and evidence of recurrence. One hundred forty patients were included with a median preoperative calcium level of 11.3 mg/dL (range, 9.6-17) and a PTH level of 147 pg/mL (range, 19-5042). The median postoperative calcium level was 9.3 mg/dL. All patients were initially eucalcemic postoperatively except for one who halo normal parathyroid levels. However, five (4%) patients required re-exploration for various reasons. Of the failures, one was secondary to the development of secondary hyperparathyroidism, and therefore would not have benefited from iPTH, one had thyroid tissue removed at the first operation, and three developed evidence of a second adenoma. One of these three patients had a drop in PTH level from 1558 pg/mL preoperatively to 64 pg/mL on postoperative Day 1, indicating that iPTH would not have prevented this failure. Thus, only three (2.1%) patients could have potentially benefited from the use of iPTH. MIRP was successful in 96 per cent of patients using a combination of preoperative sestamibi scans, intraoperative localization with a gamma probe, and the selective use of frozen pathology. This correlates with reported success rates of 95 per cent to 100 per cent using iPTH. We conclude that minimally invasive parathyroidectomy can be successfully performed without using iPTH assays.
引用
收藏
页码:785 / 789
页数:5
相关论文
共 50 条
  • [41] Role of 99mTc-sestamibi SPECT in accurate selection of primary hyperparathyroid patients for minimally invasive radio-guided surgery
    Athanasoulis, Theodore
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (04) : 607 - 608
  • [42] Role of 99Tc-sestamibi SPECT in accurate selection of primary hyperparathyroid patients for minimally invasive radio-guided surgery
    Rubello, Domenico
    Massaro, Arianna
    Cittadin, Silvia
    Rampin, Lucia
    Al-Nahhas, Adil
    Boni, Giuseppe
    Mariani, Giuliano
    Pelizzo, Maria Rosa
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (09) : 1091 - 1094
  • [43] Role of 99mTc-sestamibi SPECT in accurate selection of primary hyperparathyroid patients for minimally invasive radio-guided surgery
    Domenico Rubello
    Arianna Massaro
    Silvia Cittadin
    Lucia Rampin
    Adil Al-Nahhas
    Giuseppe Boni
    Giuliano Mariani
    Maria Rosa Pelizzo
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 1091 - 1094
  • [44] Minimally invasive parathyroidectomy results for primary hyperparathyroidism without using intraoperative parathyroid hormone assays
    Karakayali, Feza Y.
    Ekici, Yahya
    Aliosmanoglu, Ibrahim
    Aras, Murat
    Gencoglu, Arzu
    Moray, Gokhan
    TURKISH JOURNAL OF SURGERY, 2008, 24 (01) : 27 - 32
  • [45] Successful minimally invasive parathyroidectomy for primary hyperparathyroidism without using intraoperative parathyroid hormone assays
    Ollila, DW
    Caudle, AS
    Cance, WG
    Kim, HJ
    Cusack, JC
    Swasey, JE
    Calvo, BF
    AMERICAN JOURNAL OF SURGERY, 2006, 191 (01): : 52 - 56
  • [46] Role of 99mTc-sestamibi SPECT in accurate selection of primary hyperparathyroid patients for minimally invasive radio-guided surgery
    Theodore Athanasoulis
    European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 607 - 608
  • [47] Role of 99mTc-sestamibi SPECT in accurate selection of primary hyperparathyroid patients for minimally invasive radio-guided surgery -: Reply
    Rubello, Domenico
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (04) : 609 - 610
  • [48] Radio-guided surgery improves outcome of therapeutic excision in non-palpable invasive breast cancer
    Hernandez, JFG
    Tanis, PJ
    Deurloo, EE
    Nieweg, OE
    Rutgers, EJT
    Kroon, BBR
    Olmos, RAV
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (03) : 227 - 232
  • [49] From interventionist imaging to intraoperative guidance: New perspectives by combining advanced tools and navigation with radio-guided surgery
    Vidal-Sicart, S.
    Olmos, R. Valdes
    Nieweg, O. E.
    Faccini, R.
    Grootendorst, M. R.
    Wester, H. J.
    Navab, N.
    Vojnovic, B.
    van der Poel, H.
    Martinez-Roman, S.
    Klode, J.
    Wawroschek, F.
    van Leeuwen, F. W. B.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (01): : 28 - 40
  • [50] Gamma Probe Guided Minimally Invasive Parathyroidectomy without Quick Parathyroid Hormone Measurement in the Cases of Solitary Parathyroid Adenomas
    Karyagar, Savas
    Karyagar, Sevda S.
    Yalcin, Orhan
    Yuney, Enis
    Mulazimoglu, Mehmet
    Ozpacaci, Tevfik
    Karatepe, Oguzhan
    Ozdenkaya, Yasar
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2013, 22 (01) : 3 - 7